Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11462 | GPR84 antagonist 8 | GPR | Endocrinology/Hormones; GPCR/G Protein |
GPR84 antagonist 8 is a selective GPR84 antagonist. | |||
T62918 |
GPR84 antagonist 3
|
||
GPR84antagonist 3 (compound 42)为一种高效GPR84(G 蛋白偶联受体 84)拮抗剂,具pIC50值为8.28,表现出对GTPγS的抑制作用,并拥有良好的药代动力学特性。 | |||
T72536 |
GPR84 antagonist 2
|
||
GPR84antagonist 2 是一种口服有效的,选择性的 GPR84拮抗剂(IC50=8.95 nM)。GPR84antagonist 2 在钙动员试验中显示出更强的效力,并在 GPR84激活时抑制中性粒细胞和巨噬细胞的趋化性。GPR84antagonist 2 具有研究溃疡性结肠炎的潜力。 | |||
T62261 | GPR84 antagonist 1 | ||
GPR84 antagonist 1 是一种强选择性的、高亲和力的人 GPR84 竞争性拮抗剂。 | |||
T12883 |
Fezagepras
PBI-4050,3-戊基苯乙酸,Setogepram |
GPR | Endocrinology/Hormones; GPCR/G Protein |
Fezagepras (Setogepram) 是一种可口服的 GPR40激动剂和GPR84拮抗剂或反向激动剂。它减轻肾、肝和胰腺纤维化,具有抗纤维化、抗炎和抗增殖作用。 | |||
T2036 |
6-OAU
GTPL5846 |
GPR | Endocrinology/Hormones; GPCR/G Protein |
6-OAU (GTPL5846) 是 GPR84 的替代激动剂,在 Gqi5 嵌合体存在的情况下,在 HEK293 细胞中激活人 GPR84,在 PI 测定中 EC50 为 105 nM。 | |||
T11411 |
GLPG1205
|
GPR; Others | Endocrinology/Hormones; GPCR/G Protein; Others |
GLPG1205是一种有效的、具有口服活性的 GPR84(G 蛋白偶联受体)拮抗剂,具有抗炎活性 。GLPG1205显示出良好的PK/PD 特征,可用于研究肺纤维化。 | |||
T12375 |
Fezagepras sodium
Setogepram sodium salt,PBI-4050 sodium salt |
GPR | Endocrinology/Hormones; GPCR/G Protein |
Fezagepras sodium (Setogepram sodium salt) 是口服有效的 GPR40 激动剂及 GPR84 拮抗剂或反向激动剂。Fezagepras sodium 可以减轻肝,肾和胰腺纤维化。Fezagepras sodium 具有抗炎,抗增殖和抗纤维化作用。 | |||
T69860 |
PSB-15160
|
||
PSB-15160是治疗雌激素依赖性肿瘤的化合物,对MCF7(乳腺)、NCI-H460(肺)和SF-268 (NCS)细胞的生长具有抑制作用。 | |||
T68805 |
PSB-1584
|
||
PSB-1584 is a Potent Agonist of the Orphan G Protein-Coupled Receptor 84 (GPR84). GPR84, a Gi protein-coupled receptor that is activated by medium-chain (hydroxy)fatty acids, appears to play an important role in inflammation, immunity, and cancer. | |||
T69824 | PSB-17365 | ||
PSB-17365 is a potent GPR84 agonist. PSB-17365 exhibits EC50 values vs. GPR84 of 2.5nM in a cAMP accumulation assay, and 100nM in a β-arrestin 2 recruitment assay. No direct binding affinities are provided. PSB-17365 is selective for GPR84 compared to other free fatty acid receptors (FFAR1 and FFAR4). GPR84, a Gi protein-coupled receptor that is activated by medium-chain (hydroxy)fatty acids, appears to play an important role in inflammation, immunity, and cancer. | |||
T37907 | DL 175 | ||
Potent and selective GPR84 biased agonist (EC50 = 33 nM). Exhibits no significant activity in a panel of 168 other GPCRs. Exhibits bias for G protein signaling pathways. Induces morphological changes in primary murine bone marrow-derived macrophages (BMDMs) in a cellular impedance assay, and promotes phagocytosis by M1 polarized U937 cells. Induces migration of primary human monocytes, but has no effect on macrophage chemotaxis. | |||
T36634 |
ZQ 16
|
||
Selective medium-chain free fatty acid receptor GPR84 agonist (EC50 = 139 nM). Exhibits no response at GPR40, GPR41, GPR119 or GPR120 at 100 μM. Activates calcium mobilization, inhibits cAMP accumulation, and induces ERK1/2 phosphorylation, receptor desensitization and internalization in vitro. Liu et al (2016) Design and synthesis of 2-alkylpyrimidine-4,6-diol and 6-alkylpyridine-2,4-diol as potent GPR84 agonists. ACS Med.Chem.Lett. 7 579 PMID:27326330 |Zhang et al (2016) Discovery and characte... |